Mariko Takami, Ph.D.

2012 Microbiology and Immunology Loyola University Chicago, Chicago, IL, United States 
Immunology, Cell Biology
"Mariko Takami"


Sign in to add mentor
Makio Iwashima grad student 2012 Loyola University Chicago
 (Cell biology of Foxp3+ regulatory T cells.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hara A, Koyama-Nasu R, Takami M, et al. (2020) CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy. Cancer Immunology, Immunotherapy : Cii
Aoki T, Takami M, Takatani T, et al. (2020) Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner. Cancer Science
Toyoda T, Kamata T, Tanaka K, et al. (2020) Phase II study of α-galactosylceramide-pulsed antigen-presenting cells in patients with advanced or recurrent non-small cell lung cancer. Journal For Immunotherapy of Cancer. 8
Kamata T, Yoshida S, Takami M, et al. (2019) Immunological Features of a Lung Cancer Patient Achieving an Objective Response with Anti-PD-1 Blockade Therapy. Cancer Science
Ihara F, Sakurai D, Takami M, et al. (2019) Regulatory T cells induce CD4 NKT cell anergy and suppress NKT cell cytotoxic function. Cancer Immunology, Immunotherapy : Cii
Harada K, Ihara F, Takami M, et al. (2019) Soluble factors derived from neuroblastoma cell lines suppress dendritic cell differentiation and activation. Cancer Science
Aoki T, Takami M, Takatani T, et al. (2019) Invariant NKT Cells Recognize Leukemia Cells with T-Cell and NK Receptors in a CD1d-Independent Manner Blood. 134: 3225-3225
Tanaka K, Kanesaka Y, Takami M, et al. (2018) Role of leukotriene B4 12-hydroxydehydrogenase in α-galactosylceramide-pulsed dendritic cell therapy for non-small cell lung cancer. Biochemical and Biophysical Research Communications
Takami M, Cunha C, Motohashi S, et al. (2018) TGF-β suppresses RasGRP1 expression and supports regulatory T cell resistance against p53-induced CD28-dependent T cell apoptosis. European Journal of Immunology
Takami M, Ihara F, Motohashi S. (2018) Clinical Application of iNKT Cell-mediated Anti-tumor Activity Against Lung Cancer and Head and Neck Cancer. Frontiers in Immunology. 9: 2021
See more...